Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Foster & Motley Inc.

Key Points

• Foster & Motley Inc. reduced its stake in Intuitive Surgical, Inc. by 34.5%, owning 1,541 shares valued at $763,000 after selling 810 shares in the first quarter.
• Intuitive Surgical reported a net revenue increase of 21.4% year-over-year, with earnings per share of $2.19 for the quarter, exceeding estimates by $0.26.
• Institutional investors own 83.64% of Intuitive Surgical, with various firms adjusting their positions, reflecting a mix of increases and new stakes in the company's stock.

Foster & Motley Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 34.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,541 shares of the medical equipment provider's stock after selling 810 shares during the quarter. Foster & Motley Inc.'s holdings in Intuitive Surgical were worth $763,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC grew its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares in the last quarter. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC grew its holdings in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares in the last quarter. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter worth about $26,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $481.09 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock's 50-day moving average is $525.14 and its two-hundred day moving average is $533.73. The firm has a market cap of $172.46 billion, a P/E ratio of 67.10, a PEG ratio of 5.25 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Robert W. Baird decreased their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Barclays reduced their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $592.05.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 2,800 shares of the company's stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares of the company's stock, valued at $9,171,844.80. The trade was a 13.13% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,903 shares of company stock worth $7,932,778. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.